News

Ginger/Feverfew Combo May Relieve Migraine


 

LOS ANGELES – An over-the-counter herbal supplement touted for headache relief proved reasonably effective in treating migraines, Dr. Sheena Aurora reported at the annual meeting of the American Headache Society.

Dr. Aurora, of the Swedish Headache Center in Seattle, conducted a randomized, placebo-controlled study in which 26 patients were randomized to take GelStat Migraine or a placebo at the onset of an acute migraine headache.

Among 13 patients receiving GelStat Migraine, 8 reported headache relief after 2 hours, compared with 5 placebo patients, a statistically significant result, the investigator reported.

GelStat Migraine, a combination of ginger extract (12.5 mg) and feverfew (2.0 mg), is available in a gel-filled liquid capsule that is held under the tongue for 5–10 minutes and then swallowed.

“We think for a short benefit for somebody who's having a lot of headaches this is a safe and effective therapy,” Dr. Aurora said. “Say someone doesn't have their triptan with them. It probably gives them enough time and it doesn't have any interactions, so conceivably they could take the GelStat so they can get home.”

Although the mechanism of GelStat Migraine is not completely understood, feverfew seems to be a very nonspecific blocker of the transcription of inflammatory proteins, the investigator concluded.

Dr. Aurora's study was funded by GelStat Corp.

Recommended Reading

One Session Can Lower Prenatal Alcohol Use
MDedge Psychiatry
Group Therapy Can Help Pathological Gamblers
MDedge Psychiatry
'Adaptive Design' Promoted for Alcoholism, Depression Treatment
MDedge Psychiatry
Smoking Cessation Plans Work, but Not Accessed
MDedge Psychiatry
Cast a Wide Net With Chronic Pain
MDedge Psychiatry
Structured Sleep Eases Transformed Migraines
MDedge Psychiatry
Study: 44% of Patients Had Visual Auras With Migraine Attacks
MDedge Psychiatry
Topiramate Reduces Chronic Headache Days
MDedge Psychiatry
Managing Chronic Pain: Gaps Problematic in Primary Care
MDedge Psychiatry
Open-Ended Question Can Reveal Impact of Migraine
MDedge Psychiatry